These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33395052)

  • 1. A Case of Cerebral Infarction During Treatment With Rivaroxaban for Venous Thromboembolism.
    Kitahara K; Momo K; Nimura S; Okazaki K; Suzuki N; Kubota Y; Tsunoda T; Watanabe D; Mizuma K; Ono K; Sasaki T
    Am J Ther; 2022 Nov-Dec 01; 29(6):e673-e676. PubMed ID: 33395052
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombophilia testing in patients receiving rivaroxaban or apixaban for the treatment of venous thromboembolism.
    Kovacs MR; Lazo-Langner A; Louzada ML; Kovacs MJ
    Thromb Res; 2020 Nov; 195():231-232. PubMed ID: 32799129
    [No Abstract]   [Full Text] [Related]  

  • 3. "Effect of polypharmacy on bleeding with rivaroxaban versus vitamin K antagonist for treatment of venous thromboembolism": Comment.
    Lijfering WM
    J Thromb Haemost; 2022 Jul; 20(7):1747. PubMed ID: 35754012
    [No Abstract]   [Full Text] [Related]  

  • 4. "Effect of polypharmacy on bleeding with rivaroxaban versus vitamin K antagonist for treatment of venous thromboembolism": Reply.
    Bistervels IM; Bavalia R; Middeldorp S; Coppens M
    J Thromb Haemost; 2022 Jul; 20(7):1748-1749. PubMed ID: 35754011
    [No Abstract]   [Full Text] [Related]  

  • 5. Utility of Rivaroxaban for Real-World Patients With Venous Thromboembolism.
    Yamashita Y
    Circ J; 2023 Aug; 87(9):1185-1186. PubMed ID: 37225452
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data.
    Kushnir M; Choi Y; Eisenberg R; Rao D; Tolu S; Gao J; Mowrey W; Billett HH
    Lancet Haematol; 2019 Jul; 6(7):e359-e365. PubMed ID: 31133411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary Venous Thromboembolism in an Acutely Ill Medical Patient Receiving Rivaroxaban.
    Saleem A
    J Coll Physicians Surg Pak; 2017 Sep; 27(9):S129-S130. PubMed ID: 28969751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rivaroxaban-induced liver injury: Results from a venous thromboembolism registry.
    Lambert A; Cordeanu M; Gaertner S; Nouri S; Alt M; Stephan D
    Int J Cardiol; 2015 Jul; 191():265-6. PubMed ID: 25981364
    [No Abstract]   [Full Text] [Related]  

  • 9. Effectiveness and Safety of Rivaroxaban Versus Warfarin in Frail Patients with Venous Thromboembolism.
    Coleman CI; Turpie AGG; Bunz TJ; Beyer-Westendorf J
    Am J Med; 2018 Aug; 131(8):933-938.e1. PubMed ID: 29526541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing Length of Stay Between Patients Taking Rivaroxaban and Conventional Anticoagulants for Treatment of Venous Thromboembolism.
    Desai A; Desai A; Calixte R; Aparnath M; Hindenburg A; Salzman S; Mathew JP
    Lung; 2016 Aug; 194(4):605-11. PubMed ID: 27192990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rivaroxaban for the treatment of venous thromboembolism. The SWIss Venous ThromboEmbolism Registry (SWIVTER).
    Kucher N; Aujesky D; Beer JH; Mazzolai L; Baldi T; Banyai M; Hayoz D; Kaeslin T; Korte W; Escher R; Husmann M; Frauchiger B; Baumgartner I; Spirk D
    Thromb Haemost; 2016 Aug; 116(3):472-9. PubMed ID: 27346301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative risk of major bleeding with rivaroxaban and warfarin: Population-based cohort study of unprovoked venous thromboembolism.
    Kohn CG; Bunz TJ; Beyer-Westendorf J; Coleman CI
    Eur J Haematol; 2019 Feb; 102(2):143-149. PubMed ID: 30328143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of rivaroxaban use in patients with gynecologic malignancies at an academic medical center: A pilot study.
    Signorelli JR; Gandhi AS
    J Oncol Pharm Pract; 2019 Mar; 25(2):362-368. PubMed ID: 29157146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of gender on safety and efficacy of Rivaroxaban in adolescents & young adults with venous thromboembolism.
    Krause M; Henningsen A; Torge A; Juhl D; Junker R; Kenet G; Kowalski D; Limperger V; Mesters R; Anonymous ; Rocke A; Shneyder M; Clausnizer H; Schiesewitz H; Nowak-Göttl U
    Thromb Res; 2016 Dec; 148():145-151. PubMed ID: 27687905
    [No Abstract]   [Full Text] [Related]  

  • 15. Rivaroxaban versus warfarin treatment among morbidly obese patients with venous thromboembolism: Comparative effectiveness, safety, and costs.
    Spyropoulos AC; Ashton V; Chen YW; Wu B; Peterson ED
    Thromb Res; 2019 Oct; 182():159-166. PubMed ID: 31493618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
    Coleman CI; Bunz TJ; Turpie AGG
    Thromb Haemost; 2017 Oct; 117(10):1841-1847. PubMed ID: 28640322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence of malignancy-associated venous thromboembolism among patients treated with rivaroxaban compared to enoxaparin.
    Nicklaus MD; Ludwig SL; Kettle JK
    J Oncol Pharm Pract; 2018 Apr; 24(3):185-189. PubMed ID: 29284351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rivaroxaban versus Low-Molecular-Weight Heparin for Venous Thromboembolism in Gastrointestinal and Pancreatobiliary Cancer.
    Lee JH; Oh YM; Lee SD; Lee JS
    J Korean Med Sci; 2019 Jun; 34(21):e160. PubMed ID: 31144482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Rivaroxaban in Patients with Venous Thromboembolism and Active Malignancy: A Single-Center Registry.
    Bott-Kitslaar DM; Saadiq RA; McBane RD; Loprinzi CL; Ashrani AA; Ransone TR; Wolfgram AA; Berentsen MM; Wysokinski WE
    Am J Med; 2016 Jun; 129(6):615-9. PubMed ID: 26797081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of apixaban and rivaroxaban in obese patients with acute venous thrombosis/embolism.
    Anusim N; Ghimire B; Smalley M; Jaiyesimi I; Gaikazian S
    Eur J Haematol; 2022 Oct; 109(4):409-412. PubMed ID: 35739626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.